Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Beijing Major Respiratory Infectious Disease Research Center Project (BJRID225-013)
Excellent Clinical Research Program for Research Wards of Beijing Municipal Health Commission (BRWEP2024W042160109)
Beijing Medical Management Center Yangfan 3.0 Project (ZLRK202331)
- License Information
-
More Information
Article History
Received: 25 August 2025
Accepted: 20 October 2025
First Online: 2 December 2025
Declarations
:
: Weili Li, Tao Chen, and Fangxue Shen are employed by Shanghai MicuRx Pharmaceutical Co., Ltd. Wenjuan Nie and Fan Wu have nothing to disclose.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
